These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1635892)

  • 1. Pharmacokinetics of heptastigmine in rats.
    Segre G; Cerretani D; Baldi A; Urso R
    Pharmacol Res; 1992; 25(2):139-46. PubMed ID: 1635892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.
    Greig NH; De Micheli E; Holloway HW; Yu QS; Utsuki T; Perry TA; Brossi A; Ingram DK; Deutsch J; Lahiri DK; Soncrant TT
    Acta Neurol Scand Suppl; 2000; 176():74-84. PubMed ID: 11261809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects.
    Auteri A; Mosca A; Lattuada N; Luzzana M; Zecca L; Radice D; Imbimbo BP
    Eur J Clin Pharmacol; 1993; 45(4):373-6. PubMed ID: 8299673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat.
    van Beijsterveldt L; Geerts R; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2004; 54(2):85-94. PubMed ID: 15038457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
    Somani SM; Khalique A
    Drug Metab Dispos; 1987; 15(5):627-33. PubMed ID: 2891478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients.
    Hartvig P; Wiklund L; Lindström B
    Acta Anaesthesiol Scand; 1986 Feb; 30(2):177-82. PubMed ID: 3705906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid potentiometric determination of cholinesterases in plasma and red cells: application to eptastigmine monitoring.
    Cazzola E; Lattuada N; Zecca L; Radice D; Luzzana M; Imbimbo BP; Auteri A; Mosca A
    Chem Biol Interact; 1993 Jun; 87(1-3):265-8. PubMed ID: 8343985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
    Somani SM
    Biopharm Drug Dispos; 1989; 10(2):187-203. PubMed ID: 2706318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue distribution of olanzapine in rats.
    Aravagiri M; Teper Y; Marder SR
    Biopharm Drug Dispos; 1999 Nov; 20(8):369-77. PubMed ID: 10870093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration.
    Somani SM; Khalique A
    Fundam Appl Toxicol; 1986 Feb; 6(2):327-34. PubMed ID: 3699321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers.
    Imbimbo BP; Licini M; Schettino M; Mosca A; Onelli E; Zecca L; Giustina A
    J Clin Pharmacol; 1995 Mar; 35(3):285-90. PubMed ID: 7608318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.
    Giacobini E; Somani S; McIlhany M; Downen M; Hallak M
    Neuropharmacology; 1987 Jul; 26(7B):831-6. PubMed ID: 3658115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of alpha-dihydroergocriptine in rats after single intravenous and single and repeated oral administrations.
    Coppi G; Silingardi S
    Biopharm Drug Dispos; 1995 May; 16(4):333-42. PubMed ID: 7548782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ambenonium, a reversible cholinesterase inhibitor, in rats.
    Yamamoto K; Kohda Y; Sawada Y; Iga T
    Biopharm Drug Dispos; 1991 Nov; 12(8):613-25. PubMed ID: 1801966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
    Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease.
    Asthana S; Greig NH; Hegedus L; Holloway HH; Raffaele KC; Schapiro MB; Soncrant TT
    Clin Pharmacol Ther; 1995 Sep; 58(3):299-309. PubMed ID: 7554703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
    Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
    J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of two inhibitors on brain cholinesterase.
    Hallak M; Giacobini E
    Neuropharmacology; 1987 Jun; 26(6):521-30. PubMed ID: 3601008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.